Sanofi, INE058A01010

Sanofi India stock: GST notice dropped after INR 17,680 payment

Published on 11/20/2026 at 02:51 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Sanofi India stock faces no further liability after a Bengaluru GST order closed the case. The ruling leaves operations financially unaffected.

Tax case closes with limited payment

  • The Bengaluru tax authority dropped a proposed INR 23.74 crore input-tax-credit demand after Sanofi India paid INR 17,680.
  • The company said the order has no material impact on its financial, operational or other activities.
Sanofi, INE058A01010, Illustration mit AI erstellt.

Sanofi India said a Bengaluru tax proceeding ended on November 16, 2026, after the company paid INR 17,680 in tax and interest. Medical Dialogues reported that the adjudication order closed the matter and removed any further payment obligation.

GST demand withdrawn after review

The case began with a show-cause notice dated September 25, 2026, concerning alleged excess input tax credit for the financial year 2022-23. The notice had proposed a tax liability of INR 23.74 crore.

The Commercial Tax Officer (Audit)-6.1 in Bengaluru concluded the proceedings under Section 73 of the Karnataka Goods and Services Tax Act, 2017. The payment comprised INR 10,128 in central and state goods and services tax and INR 7,552 in interest, relating to certain blocked-credit items.

The authority dropped the show-cause notice after considering Sanofi India's explanations and representations. The company said the order would have no material impact on its financial, operational or other activities, limiting the direct investor relevance to closure of the tax dispute rather than a change to its operating outlook.

India business remains focused on healthcare

Sanofi India supplies healthcare products in India, with activities spanning preventive healthcare vaccines and therapies for diabetes, rare diseases and transplant needs. It is part of the global Sanofi Group and serves the Indian pharmaceutical market through these therapeutic areas.

Sanofi India at a glance

  • Company: Sanofi India Limited
  • ISIN: INE058A01010
  • NSE symbol: SANOFI
  • Listing status: Listed and active on the National Stock Exchange of India as of November 13, 2026
  • Tax order: November 16, 2026

India's broader market environment is covered in current market reports.

More news and analyses on Sanofi India stock.

Disclaimer...
en | INE058A01010 | SANOFI | boerse | 70538316 | bgmi